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KEYWORDS	
	 Three	 simple	 and	 sensitive	 methods	 were	 developed	 for	 the	 determination	 of	 acemetacin
(ACM)	 in	 presence	 of	 its	 degradation	 product,	 indomethacin	 (DEG).	 Several	 methods	 were
evaluated	and	are	presented.	Method	A	was	based	on	measuring	 the	peak	amplitude	of	 the
first	 derivative	 of	 the	 ratio	 spectra	 1DD	 at	 244	 nm.	 In	 method	 B,	 mean	 centering	 of	 ratio
spectra	method	(MCR)	was	applied,	which	depends	on	measuring	the	mean	centered	values	of
ratio	spectra	of	ACM	at	234	nm.	Method	C	provided	separation	of	ACM	from	its	DEG	on	pre‐
activated	silica	gel	60F254	HPTLC	plates	using	hexane:ethyl	acetate:glacial	acetic	acid	(6:4:0.3,
v:v:v)	 as	 developing	 system	 followed	 by	 scanning	 at	 254	 nm.	 The	 suggested	methods	were
validated	in	compliance	with	the	International	Conference	on	Harmonisation	(ICH)	guidelines
and	 were	 successfully	 applied	 for	 quantification	 of	 ACM	 in	 its	 commercial	 capsule.	 The
proposed	 methods	 were	 also	 statistically	 compared	 to	 a	 reported	 HPLC	 method	 with	 no
significant	 difference	 in	 performance;	 indicating	 the	 ability	 of	 the	 proposed	 method	 to	 be
reliable	and	suitable	for	routine	analysis	of	drug	product.		
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1.	Introduction	
	
Acemetacin	 (ACM),	 [1‐(4‐chlorobenzoyl)‐5‐methoxy‐2‐
methylindol‐3‐yl]	 acetyloxy	 acetic	 acid	 [1],	 is	 a	 non‐steroidal	
anti‐inflammatory	drug	(NSAID)	used	in	musculoskeletal,	 joint	
disorder,	 rheumatoid	 arthritis	 and	 for	 treatment	 of	 post‐
operative	pain	and	inflammation	[2].	Being	a	glycolic	acid	ester	
of	 indometacin	 (NSAID);	 50‐90%	 of	 absorbed	 Acemetacin	 is	
converted	inside	the	body	into	indomethacin	where	both	exert	
their	anti‐inflammatory	action	by	the	same	mechanism	[3].	
The	 literature	 survey	 reveals	 several	 methods	 for	
determination	of	Acemetacin	in	its	pharmaceutical	preparation	
including	 direct	 UV,	 derivative	 UV	 spectrophotometry	 and	
HPLC	[4]	and	micellar	liquid	chromatograpgy	[5].	The	effect	of	
micelles	 on	 the	 spectroscopic	 and	 solubility	 properties	 of	 the	
two	non‐steroidal	 anti‐inflammatory	drugs,	 indomethacin	 and	
Acemetacin,	was	studied	at	different	pH	values	[6].	Application	
of	 Partial	 Least	 Square	 (PLS)	 chemometric	 method	 for	
resolving	 a	mixture	 of	 Acemetacin	 and	 indomethacin	mixture	
was	reported	[7].	Additionally,	it	was	determined	in	plasma	as	
well	by	and	HPLC	[8‐10]	and	voltammetry	[11].		
None	 of	 the	 reported	methods	 have	 described	 a	 stability‐
indicating	 method	 for	 the	 determination	 of	 ACM	 in	 capsule	
dosage	 form.	 Therefore,	 the	 aim	 of	 this	 manuscript	 is	 to	
establish	 and	 validate	 stability‐indicating	 methods	 for	 the	
determination	 of	 active	 compound	 in	 the	 presence	 of	 its	
degradation	 product.	 To	 establish	 the	 stability‐indicating	
nature	 of	 the	 methods,	 forced	 degradation	 of	 ACM	 was	
performed	under	stress	conditions,	and	stressed	samples	were	
analyzed	 by	 use	 of	 the	 proposed	 spectrophotometric	 and	
HPTLC	methods,	which	were	 able	 to	 separate	 the	 drugs	 from	
compound	produced	during	forced	degradation	studies.	
	
2.	Experimental	
	
2.1.	Instruments	
	
A	 double	 beam	 UV‐VIS	 spectrophotometer	 (SHIMADZU,	
Japan)	model	UV‐1601	PC	with	quartz	cell	of	1	cm	pathlength,	
connected	 to	 IBM	 compatible	 computer.	 The	 software	 was	
UVPC	 personal	 spectroscopy	 software	 version	 3.7.	 Data	
concerning	MCR	was	performed	using	PLS‐Toolbox	2.0	running	
under	MATLAB®,	version	(R2007b).	Camag	TLC	scanner	3	S/N	
130319	 operated	 with	 winCATS	 software.	 The	 following	
requirements	are	taken	into	consideration:	Slit	dimensions:	6	×	
0.3	mm,	scanning	speed:	20	mm/s,	spraying	rate:	10	s/µL,	data	
resolution:	 100	 µm/step,	 band	 width:	 6	 mm,	 result	 output:	
Chromatogram	and	integrated	peak	area,	Linomat	IV	with	100	
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μL	 syringe	 (Camag,	 Muttenz,	 Switzerland),	 HPTLC	 aluminum	
plates	 (20	 x	 20	 cm)	 coated	 with	 0.25	 mm	 silica	 gel	 60F254	
(Merck,	Germany).	Sonix	TV	ss‐series	ultrasonicator	(USA).	
	
2.2.	Material	and	reagents	
	
2.2.1	Pure	standard	
	
ACM	 was	 purchased	 from	 Sigma‐Aldrich	 through	 the	
Egyptian	 International	 Center	 for	 import	 and	 export	 (EIC,	
Egypt).	 Its	purity	was	certified	 to	be	98.00%	according	 to	 the	
company’s	 certificate	 of	 analysis.	 Indomethacin	 was	 kindly	
supplied	by	Pharco	Pharmaceuticals	Co.,	Egypt.	
	 	
2.2.2.	Pharmaceutical	preparation	
	
Ostmap®	 capsules	 batch	 No	 (MT	 3710911)	 were	
manufactured	 by	 Multi‐Apex	 Pharmaceutical	 Industries	 Co.	
(Maisons‐Alfort,	France),	each	capsule	is	claimed	to	contain	60	
mg	of	ACM.	
	
2.2.3.	Chemicals	and	reagents	
	
All	 chemicals	 and	 solvents	 used	 were	 of	 analytical	 grade,	
methanol	 (E.	 Merck,	 Germany).	 Purified	 water	 (3A	
international	 Co.,	 Kalubia,	 Egypt).	 Sodium	 hydroxide,	
hydrochloric	 acid,	 30%	 hydrogen	 peroxide	 solution,	 hexane,	
ethyl	 acetate	 and	 glacial	 acetic	 acid	 (El‐Nasr	 Pharmaceutical	
Chemicals	Co.,	Abu‐Zabaal,	Cairo,	Egypt).	
	
2.2.4.	Degraded	sample		
	
A	 stock	 solution	 containing	 0.1	 g	 of	 ACM	 in	 100	 mL	
methanol	 was	 prepared.	 This	 solution	 was	 used	 for	 forced	
degradation	 under	 variety	 of	 conditions	 such	 as:	 acid	 and	
alkaline	hydrolysis,	oxidation	and	photodegradation.		
Alkaline	hydrolysis	was	performed	by	adding	5	mL	of	0.1	M	
NaOH	solution	to	5	mL	of	ACM	stock	solution	and	standing	for	
about	 30	 minutes	 at	 room	 temperature.	 Acid	 hydrolysis	 was	
carried	out	by	refluxing	with	0.1	M	HCl	at	80	°C	for	about	4	h.	
Oxidation	 studies	 were	 implemented	 using	 30%	 hydrogen	
peroxide	solution.	Finally,	photochemical	stability	was	studied	
by	exposing	the	drug	sample	to	daylight	for	24	hours.		
Appropriate	 volume	 of	 the	 resultant	 solution	was	 applied	
on	TLC	plate	where	complete	degradation	was	followed	up	via	
TLC	 using	 hexane:	 ethyl	 acetate:	 glacial	 acetic	 acid	 (6:4:0.3,	
v:v:v)	as	developing	system	till	complete	disappearance	of	ACM	
spot.	 Pure	 standard	 of	 indomethacin	 solution	 was	 used	 for	
comparison	 and	 its	 Rf	 was	 coinciding	 with	 the	 resultant	
degradation	 product	 (DEG).	 Furthermore,	 the	 degradation	
product	was	elucidated	by	IR	and	mass	spectrometry.	
	
2.3.	Standard	solutions	
	
Stock	standard	solutions	of	ACM	and	DEG	1	mg/mL	of	each	
in	methanol.	Working	standard	solutions	of	ACM	and	DEG	100	
µg/mL	of	each	 in	methanol.	All	 stock	standard	solutions	were	
freshly	 prepared	 on	 the	 day	 of	 analysis	 and	 stored	 in	
refrigerator	to	be	used	within	24	h.	
	
2.4.	Methods	
	
2.4.1.	Spectrophotometric	methods	
	
2.4.1.1.	Construction	of	calibration	curve	for	1DD	
spectrophotometric	method	
	
Accurately	 measured	 aliquots	 equivalent	 to	 20‐220	 µg	 of	
ACM	were	 transferred	 from	its	working	solution	(100	µg/mL)	
into	 a	 series	 of	 10	 mL	 volumetric	 flasks.	 The	 volume	 was	
completed	with	purified	water	 to	 obtain	 a	 final	 concentration	
range	 (2‐22	µg/mL).	 1DD	curves	were	 recorded	 at	Δλ	=	4	nm	
and	scaling	factor	=	10.	The	absorption	spectra	of	this	solution	
were	divided	by	the	absorption	spectrum	of	20	µg/mL	of	DEG	
(as	 a	 divisor),	 and	 then	 the	 obtained	 ratio	 spectra	 were	
differentiated	with	respect	to	wavelength.	The	peak	amplitudes	
at	 244	 nm	 were	 recorded	 then	 calibration	 graph	 was	
constructed	 relating	 the	 peak	 amplitudes	 of	 (1DD)	 to	 the	
corresponding	 concentrations.	 The	 regression	 equation	 was	
then	computed	for	the	studied	drug	at	the	specified	wavelength	
and	 used	 for	 determination	 of	 unknown	 samples	 containing	
ACM.		
	
2.4.1.2.	Construction	of	calibration	curves	for	mean	
centering	of	ratio	spectra	spectrophotometric	method	(MCR)	
	
Accurately	 measured	 aliquots	 equivalent	 to	 20‐220	 µg	 of	
ACM	were	transferred	 from	its	working	solution	(100	µg/mL)	
into	 a	 series	 of	 10	mL	 volumetric	 flasks	 and	 the	 volume	was	
completed	with	purified	water	to	final	concentration	range	(2‐
22	µg/mL).	
The	recorded	absorption	spectra	of	ACM	from	220‐320	nm	
were	divided	by	the	absorption	spectrum	of	DEG	(20	µg/mL)	to	
obtain	the	ratio	spectra,	which	were	then	mean	centered.	These	
mean	 centered	 values	 of	 the	 ratio	 spectra	 at	 234	 nm	 were	
recorded	and	plotted	versus	the	corresponding	concentrations.	
Calibration	curve	was	constructed	and	regression	equation	was	
computed.	
	
2.4.1.3.	Analysis	of	laboratory	prepared	mixtures	containing	
different	ratios	of	acemetacin	and	its	degradation	product	
using	the	suggested	methods	
	
Aliquots	of	intact	drug	and	the	DEG	were	mixed	to	prepare	
different	 mixtures	 containing	 10‐90%	 of	 the	 degradation	
product,	 and	 proceed	 as	 mentioned	 under	 each	method.	 The	
concentrations	 were	 calculated	 from	 the	 corresponding	
regression	equations.	
	
2.4.2.	HPTLC	chromatographic	method	
	
2.4.2.1.	Construction	of	calibration	curve	for	HPTLC‐
densitometric	method	
	
Aliquots	equivalent	to	0.4‐1.4	mg	of	ACM	were	transferred	
from	its	standard	solution	(1	mg/mL	in	methanol)	into	a	series	
of	10	mL	measuring	flasks,	then	the	volume	of	each	flask	were	
completed	 to	 volume	 with	 methanol.	 10	 µL	 of	 each	 solution	
were	 applied	 in	 triplicate	 to	 HPTLC	 plates	 (20	 ×	 11	 cm)	 as	
bands	with	6	mm	width	using	a	Camag	Linomat	 IV	applicator.	
The	 bands	 were	 spaced	 5	 mm	 from	 each	 other	 and	 10	 mm	
apart	 from	 the	 bottom	 edge	 of	 the	 plate.	 Linear	 ascending	
development	 was	 performed	 in	 a	 chromatographic	 chamber	
previously	 saturated	 with	 hexane:ethyl	 acetate:glacial	 acetic	
acid	(6:4:0.3,	v:v:v)	as	a	developing	system	for	one	hour	at	room	
temperature	 to	 a	 distance	of	 9	 cm.	The	 integrated	peak	 areas	
were	recorded	using	scanning	wavelength	at	254	nm	under	the	
specified	 instrumental	 conditions.	 The	 calibration	 curve	
constructed	 by	 plotting	 the	 mean	 integrated	 peak	 area/103	
versus	 the	 corresponding	 concentration	 of	 ACM	 and	 then	 the	
regression	equation	was	computed.	
	
2.4.3	Assay	of	pharmaceutical	formulation	(Ostmap®	
capsules)	
	
The	contents	of	twenty	capsules	of	Ostmap®	were	weighed	
and	mixed	well.	 An	 accurately	weighed	 portion	 equivalent	 to	
100	mg	of	ACM	was	 transferred	 into	100	mL	volumetric	 flask	
and	 then	 75	mL	methanol	was	 added.	 The	 prepared	 solution	
was	sonicated	for	30	min,	cooled	and	completed	to	volume	with	
methanol.	The	solution	was	 filtered	and	diluted	 to	obtain	100	
µg/mL	working	solution	for	each	method.		
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Figure	1. Chemical	structure	of	Acemetacin	(ACM).
	
	
 
 
Figure	2.	Pathway	of	ACM	hydrolytic	degradation.
	
	
The	procedure	detailed	under	linearity	and	construction	of	
calibration	curve	for	each	method	was	followed.	When	carrying	
out	the	standard	addition	technique,	the	powder	content	of	the	
capsules	and	that	of	pure	ACM	were	mixed	well	together	before	
proceeding	in	the	above‐mentioned	procedures.		
	
3.	Results	and	discussion	
	
Acemetacin	is	regarded	as	a	pro‐drug	of	indomethacin	[12],	
both	 drugs	 have	 the	 same	 efficiency,	 but	 with	 regard	 to	
tolerability,	 the	 incidence	 and	 severity	 of	 gastro‐intestinal	
adverse	 effects	 was	 significantly	 less	 with	 Acemetacin	 than	
with	 indomethacin	 as	 it	 induced	 more	 gastric	 damage,	 and	
central	 nervous	 system	 adverse	 effects	 were	 also	 markedly	
fewer.	 So	 Acemetacin	 is	 as	 effective	 as	 indomethacin	 in	 the	
treatment	 of	 rheumatoid	 arthritis,	 but	 has	 significant	
advantages	 in	 terms	 of	 tolerability	 and	 safety	 [13].	 Thus	 the	
main	 task	 of	 this	 work	 was	 to	 study	 the	 stability	 of	 ACM	
according	to	ICH	guidelines	[14]	for:	
(a)	 Stress	 alkaline	 hydrolysis:	 0.1	 M	 NaOH	 at	 room	
temperature	for	30	min.		
(b)	Stress	acid	hydrolysis:	0.1	M	HCl	at	80	°C	for	4	h.	
(c)	Oxidative	condition:	30%	H2O2	for	24	h.	
(d)	 Photochemical	 stability	 was	 studied	 by	 exposing	 the	
drug	sample	to	daylight	for	24	h.	
Being	 an	 ester;	 ACM	 (Figure	 1)	 was	 easily	 hydrolyzed	 in	
alkaline	 medium	 using	 0.1	 M	 NaOH	 into	 corresponding	 acid;	
indomethacin.	It	was	also	hydrolyzed	to	the	same	degradation	
product	by	refluxing	with	0.1	M	HCl	for	about	4	h.	The	resultant	
solution	after	both	alkaline	and	acid	hydrolysis	was	compared	
to	the	pure	standard	indomethacin	via	TLC	using	hexane:	ethyl	
acetate:	glacial	acetic	acid	(6:4:0.3,	v:v:v)	as	developing	system.	
The	 resultant	 degradation	 product	 was	 compared	 with	 the	
authentic	indomethacin	on	TLC	plate	and	both	shows	the	same	
Rf	 values.	 Degradation	 pathway	 of	 ACM	 is	 shown	 in	 Figure	 2.	
ACM	 showed	 stability	 regarding	 both	 oxidation	 and	 photo‐
stability	studies.	
Moreover,	 both	 ACM	 and	 DEG	 were	 characterized	 by	 IR‐	
and	 MS‐spectrometry;	 Figures	 3	 and	 4.	 IR	 spectrum	 of	 ACM	
shows	 four	 characteristic	 bands	 at	 about	 1605.5,	 1667.2,	
1723.1	 cm‐1	 indicating	 three	 carbonyl	 groups	 of	 amide,	
carboxylic	 acid	 and	 ester	 respectively	 [15].	 A	 broad	 peak	
appeared	 at	 2937.1	 cm‐1	 indicating	 the	 peripheral	 hydroxyl	
group	[15].	The	IR	spectrum	of	DEG	indicates	the	disappearance	
of	 the	 1723.1	 cm‐1	 ester	 carbonyl	 group	 peak.	 This	 result	 was	
confirmed	by	mass	spectra,	where	the	MS	chart	of	ACM	shows	
parent	 peak	 identified	 at	 m/z	 415	 (corresponding	 to	 the	
molecular	weight	of	ACM)	while	MS	chart	of	DEG	shows	parent	
peak	 at	m/z	 357	 (corresponding	 to	 the	 molecular	 weight	 of	
DEG).	
	
	(a)	
	
	(b)	
Figure	3.	IR	spectra	of	(a)	ACM	and	(b)	DEG.	
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	 	(a)	
	
	(b)	
	
Figure	4.	Mass	spectra	of	(a)	ACM		and	(b)	DEG.	
	
	
3.1.	Spectrophotometric	methods	
	
3.1.1.	1DD	spectrophotometric	method	
	
The	 zero‐order	 absorption	 spectra	 of	 ACM	 and	 its	 DEG	
show	 sever	 or	 even	 complete	 overlapping	 (Figure	 5),	 which	
interferes	with	the	direct	spectrophotometric	determination	of	
ACM	in	presence	of	its	DEG.	Derivative	ratio	spectroscopy	is	an	
analytical	 technique	 of	 great	 utility	 for	 resolving	 overlapped	
spectra,	 by	 applying	 this	 technique	 selective	 determination	 of	
ACM	 in	presence	of	DEG	was	achieved	by	measuring	 the	peak	
amplitude	at	244	nm	as	shown	in	Figure	6.	
	
 
 
Figure	 5.	 Zero	 order	 absorption	 spectra	 of	 8	 µg/mL	 of	 ACM	 	(ــــــ) and	 8	
µg/mL	of	DEG	(ــ ــ ــ)	using	purified	water	as	a	blank.	
 
 
 
 
Figure	6.	First	derivative	of	the	ratio	spectra	of	16	µg/mL	of	ACM	(ــــــ)	and	
16	µg/mL	of	DEG	(ــ ــ ــ)	using	20	µg/mL	of	DEG	as	divisor	and	purified	water	
as	a	blank.	
	
3.1.2.	Mean	centering	of	ratio	spectra	spectrophotometric	
method	(MCR)	
	
The	 developed	 MCR	 method	 depends	 on	 the	 mean	
centering	of	the	ratio	spectra,	it	eliminates	the	derivative	steps	
and	 so	 signal‐to‐noise	 ratio	 is	 enhanced	 [16].	 It	 has	 been	
applied	 for	 resolving	 binary	 and	 ternary	mixtures	 in	 complex	
samples	 with	 unknown	 matrices	 [17].	 The	 mathematical	
explanation	 of	 the	 method	 was	 obtained	 and	 illustrated	 by	
Afkhami	and	Bahram	[18].	
The	main	step	in	the	development	of	an	analytical	method	
is	 to	 optimize	 the	 conditions	 and	 parameters,	 which	 will	 be	
followed	 in	 development	 and	 validation	 to	 obtain	 the	 best	
results.	 To	 optimize	 the	 1DD	 and	 mean	 centering	
spectrophotometric	 methods,	 it	 was	 necessary	 to	 test	 the	
influence	of	the	following	variables:	
	
3.1.2.1.	Solvents	
	
Different	 solvents	 were	 studied	 (methanol,	 ethanol,	
isopropanol,	 acetonitrile,	 purified	water,	 0.1	M	HCl	 and	0.1	M	
NaOH).	 It	was	 found	 that	 purified	water	was	 the	 best	 solvent	
regarding	selectivity	and	sensitivity.	
	
3.1.2.2.	The	divisor	and	its	concentration	
	
The	 effect	 of	 divisor	 concentration	 on	 the	 method	
selectivity	 and	 analytical	 parameters	 such	 as	 slope,	 intercept	
and	correlation	coefficient	of	calibration	equations	was	tested.	
Different	concentrations	of	DEG	were	tested	as	a	divisor	(2,	4,	
6,	8,	16,	20	µg/mL).	It	was	found	that	20	µg/mL	of	DEG	was	the	
best	regarding	selectivity	and	sensitivity.	
	
3.1.2.3.	Smoothing	and	scaling	factors		
	
Different	 smoothing	 factor	 (Δλ)	 values	 were	 tried,	 where	
smoothing	 factor	 =	 4	 showed	 a	 suitable	 signal	 to	 noise	 ratio	
with	good	resolution.	Different	scaling	factor	values	were	tried	
where	scaling	factor	=	10	was	the	best	to	measure	the	signal	of	
ACM	and	to	decrease	the	reading	error.	
The	peak	amplitude	of	the	first	derivative	of	ratio	spectra	at	
λ	 =	 244	 nm	 (as	 shown	 in	 Figure	 7)	 was	 plotted	 versus	 the	
concentration	 of	 ACM	 in	 the	 range	 of	 2‐22	 µg/mL.	 The	
calibration	 curve	 was	 constructed	 with	 mean	 percentage	
recovery	 99.65%±0.797.	 The	 following	 linear	 regression	
equation	was	obtained:		
	
Y	=	0.0039C	+	0.0024,	r	=	0.9999	 	 	 (1)	
	
where	Y	is	the	peak	amplitude	at	244	nm,	C	is	the	concentration	
in	µg/mL	and	r	is	the	correlation	coefficient.	
	
Figure	 7.	 First	 derivative	 of	 ratio	 spectra	 of	 of	 ACM	 in	 the	 range	 of	 2‐22	
µg/mL	using	20	µg/mL	DEG	as	a	divisor	purified	water	as	blank.	
	
While	the	absorption	spectra	of	ACM	were	recorded	in	the	
wavelength	range	of	220‐320	nm	and	divided	by	the	absorption	
spectrum	 DEG	 (20	 µg/mL)	 to	 obtain	 the	 ratio	 spectra	 which	
were	then	mean	centered.	ACM	was	determined	by	measuring	
the	peak	amplitude	at	234	nm	which	corresponds	to	maximum	
wavelength	 as	 shown	 in	 Figure	 8.	 The	 peak	 amplitude	 was	
plotted	versus	the	corresponding	concentration	in	the	range	of	
2‐22	µg/mL.	The	calibration	curve	was	constructed	with	mean	
percentage	 recovery	 99.30%±1.146.	 The	 following	 linear	
regression	equation	was	obtained:		
	
Y	=	0.003	C	+	0.003,	r	=	0.9999	 	 	 (2)	
	
where	Y	is	the	peak	amplitude	at	234	nm,	C	is	the	concentration	
in	µg/mL	and	r	is	the	correlation	coefficient.	
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Figure	8.	The	mean	centered	ratio	absorption	spectra	of	ACM	in	the	range	of	
2‐22	µg/mL	using	purified	water	as	a	blank.	
	
3.2.	HPTLC	method	
	
Thin	 layer	 chromatography	 (TLC)	 made	 a	 great	 progress	
and	 attained	 a	wide	 acceptance	 as	 a	major	 analytical	 tool	 for	
both	 qualitative	 and	 quantitative	 methods	 of	 analysis	 and	
became	 a	 well	 established	 method	 for	 the	 assay	 of	 drugs	 in	
mixtures.	 HPTLC	 offers	 the	 advantages	 of	 automatic	
application,	 high	 separation	 and	 giving	 dense	 and	 compact	
spots	with	appropriately	and	significantly	different	Rf	values	in	
addition	 to	 high	 sensitivity	 [19].	 Accordingly,	 HPTLC	 method	
was	 successfully	 applied	 for	 separation	 of	 ACM	 and	 DEG	
mixture	and	for	quantification	of	ACM	in	presence	of	its	DEG	in	
pure	form	and	in	pharmaceutical	preparation.	
In	order	 to	optimize	 the	developed	HPTLC	method,	 it	was	
necessary	to	investigate	the	effect	of	different	factors	to	get	the	
desired	chromatographic	resolution.	
	
3.2.1.	Developing	system	and	efficiency		
	
Different	developing	systems	of	different	 composition	and	
ratios	 were	 tried	 such	 as	 chloroform:methanol	 (9:1,	 v:v),	
chloroform:methanol:ammonia	 solution	 (9:1:0.1,	 v:v:v),	
chloroform:methanol:glacial	 acetic	 acid	 (9:1:0.1,	 v:v:v),	 and	
hexane:ethyl	acetate:glacial	acetic	acid	(6:4:0.3,	v:v:v)	to	obtain	
optimum	separation	between	ACM	and	its	degradation	product	
(DEG).	 The	 best	 developing	 system	 was	 found	 to	 be	
hexane:ethyl	 acetate:glacial	 acetic	 acid	 (6:4:0.3,	 v:v:v).	 This	
selected	 developing	 system	 allowed	 good	 separation	 between	
ACM	 and	 its	 degradation	 product	 with	 satisfactory	 Rf	 values	
without	tailing	of	the	separated	bands,	as	shown	in	Figure	9.	It	
was	found	that	presence	of	glacial	acetic	acid	with	this	ratio	in	
the	developing	system	is	essential	for	separation.	
	
 
 
Figure	9.	2D	HPTLC	densitogram	of	resolved	mixtures	of	ACM	(Rf =	0.21)	and	
DEG	(Rf	=	0.51)	using	(hexane:ethyl	acetate:glacial	acetic	acid)	(6:4:0.3,	v:v:v)	as	
a	developing	system	at	254	nm. 
	
3.2.2.	Scanning	wavelength	
	
Different	 scanning	wavelengths	were	 tried	 (254,	 265	 and	
318	 nm)	 in	 order	 to	 obtain	 good	 sensitivity	 of	 ACM	 with	
minimum	noise.	The	wavelength	254	nm	was	 found	 to	be	 the	
best	 wavelength	 regarding	 sensitivity	 of	 ACM.	 Peaks	 were	
sharp	 and	 symmetrical	 with	 minimum	 noise,	 as	 shown	 in	
Figure	10.	
	
 
 
Figure	10.	HPTLC	densitogram	of	ACM	 in	 the	 concentration	 range	 (0.4‐1.4	
µg/band)	 using	 (hexane:ethyl	 acetate:glacial	 acetic	 acid)	 solution	 (6:4:0.3,	
v:v:v)	as	a	developing	system	at	254	nm.	
	
3.2.3.	Band	dimensions	
	
The	 slight	 spread	of	 the	developed	bands	due	 to	 ordinary	
diffusion	should	be	taken	into	consideration,	so	the	band	width	
and	 interspaces	 between	bands	 should	 be	 chosen	 carefully	 to	
avoid	 spread	 of	 bands	 outside	 the	 scanning	 tracks	 and	
interference	 between	 adjacent	 bands.	 Different	 band	
dimensions	were	tried	to	obtain	sharp	and	symmetrical	peaks.	
The	optimum	bandwidth	chosen	was	6	mm	and	the	inter‐space	
between	bands	was	5	mm.	
	
3.2.4.	Slit	dimensions	of	scanning	light	beam	
	
The	 slit	 dimensions	 of	 the	 scanning	 light	 beam	 should	
ensure	complete	coverage	of	band	dimensions	on	the	scanned	
track	 without	 interference	 of	 adjacent	 bands.	 Different	 slit	
dimensions	were	tried	where	6	mm	×	0.3	mm	proved	to	be	the	
slit	dimensions	of	choice	which	provided	highest	sensitivity.		
This	 method	 offers	 high	 sensitivity	 and	 selectivity	 for	
analysis	of	ACM	in	presence	of	DEG	using	hexane:	ethyl	acetate:	
glacial	acetic	acid	(6:4:0.3,	v:v:v)	as	a	developing	system,	where	
good	separation	was	obtained	by	the	difference	in	the	retention	
factor	 (Rf)	 values	 of	 ACM	 (Rf	 =	 0.21)	 and	 DEG	 (Rf	 =	 0.51)	 as	
shown	in	Figure	9.	
The	calibration	curve	for	ACM	was	constructed	by	plotting	
the	 integrated	 peak	 area/103	 versus	 the	 corresponding	
concentrations	 of	 ACM	 in	 the	 range	 of	 0.4‐1.4	 μg/band	 with	
mean	percentage	recovery	100.00±0.709.	The	concentration	of	
ACM	was	calculated	from	the	following	regression	equation:	
	
A	=	0.1944	C	+	0.0671,	r	=	0.9999	 	 	 (3)	
	
where	A	is	integrated	peak	areas/103,	C	is	the	concentration	in	
µg/band	and	r	is	the	correlation	coefficient.	
	
3.3.	Stability‐indication	
	
To	assess	the	stability‐indicating	efficiency	of	the	proposed	
methods,	 they	 were	 applied	 to	 laboratory	 prepared	 mixtures	
containing	different	ratios	of	ACM	and	DEG.		
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Table	1.	Assay	results	for	the	determination	of	ACM	in	synthetic	mixtures	with	DEG.	
DEG	%	 %	Recovery		 %	Recovery	
1DD	spectrophotometric	method Mean	centering	method	
10%	 100	 99.60
20%	 101.9	 101.60
30%	 101.1	 100.30
40%	 98.85	 99.17	
50%	 98.97	 99.00	
60%	 101.9	 102.50
70%	 100.9	 97.18	
80%	 97.44	 98.31	
90%		 93.59*	 101.90
Mean±SD	 100.13±1.610	 99.96±1.780
* Rejected	value.	
	
Table	2.	Determination	of	ACM	in	pharmaceutical	formulation	by	the	proposed	methods	and	application	of	standard	addition	technique.	
Pharmaceutical	formulation	 Ostmap®	capsules
B.N:	3710911	
Taken	(µg/mL) Found	%*	±	SD Pure	added	(µg/mL)	 Recovery	%	
1DD	method	 10.00	 101.23±1.008	 8.00	 99.04	
10.00 100.3	
12.00 97.22	
Mean±SD	 98.84±1.527
Mean	centring	spectrophotometric	
method	
10.00	 101.28±1.758 8.00 101.48	
10.00	 101.55	
12.00 100.89	
Mean±SD	 	 	 101.31±0.359	
HPTLC	method	 0.60	 99.88±1.004 0.40 101.6	
0.60	 98.83	
0.80 97.4	
Mean±SD	 99.28±2.139
*	Average	of	6	determinations.	
	
Table	3.	Regression	and	validation	parameters	of	the	proposed	methods	for	determination	of	ACM	in	presence	of	DEG.	
Parameter	 1DD	spectrophotometric	method Mean	centering	method 	HPTLC	method	
Linearity	and	range		 2‐22	µg/mL	 2‐22	µg/mL 0.4‐1.4	µg/band	
Slope	 0.0039	 0.0030 0.1944	
Intercept	 0.0024	 0.0030 0.0671	
Correlation	coefficient	(r)	 0.9999	 0.9999 0.9999	
Accuracy	 99.65%±0.797 99.30%±1.146 100.00%±0.709	
Specificity	and	Selectivity	 100.13±1.61	 99.96±1.780	 ‐	
Precision	 	 	 	
Repeatability	(RSD%)	a	 0.318‐0.056	 0.037‐0.099	 0.341‐1.358	
Intermediadte	Precision	(RSD%)	a	 0.275‐0.450	 0.057‐0.910	 2.828‐2.805	
LOD	b	 0.379	µg/mL	 0.407	µg/mL 0.050	µg/band	
LOQ	b	 1.147	µg/mL	 1.232	µg/mL 0.400	µg/band	
Robustness	 ‐	 ‐ 99.50%±0.884	
a	(RSD%)	and	(RSD%);	the	intra‐	and	inter‐day	relative	standard	deviation	of	concentrations	(6,	20	µg/mL)	for	1DD	method,	(4,	12	µg/mL)	for	MCR	method	and	
(0.6,	1.2	µg/band)	for	HPTLC	method.	
b	Limit	of	detection	and	quantitation	are	determined	via	calculations	for	1DD	and	MCR	methods	(LOD	=	3.3	×	SD/slope,	LOQ	=	10	×	SD/slope)	and	experimentally	
by	signal‐to‐noise	ratio	for	HPTLC	method	[20].	
	
	
Results	 given	 in	 Table	 1	 indicate	 that	 the	 proposed	 1DD	
method	is	valid	for	determination	of	intact	ACM	in	presence	of	
up	 to	80%	of	 its	DEG	and	mean	centering	method	 is	selective	
and	valid	for	determination	of	ACM	in	presence	of	up	to	90%	of	
its	DEG.	
As	 the	 suggested	methods	 could	 effectively	 determine	 the	
drug	 in	presence	of	 its	DEG,	 they	can	be	employed	as	stability	
indicating	ones.	
	
3.4.	Application	of	the	proposed	methods	to	the	
pharmaceutical	formulation	
	 	
The	 suggested	methods	were	 successfully	 applied	 for	 the	
determination	 of	 ACM	 in	 its	 pharmaceutical	 formulation	
(Ostmap®	capsules),	showing	good	percentage	recoveries.	The	
validity	 of	 the	 suggested	 methods	 was	 further	 assessed	 by	
applying	the	standard	addition	technique	as	shown	in	Table	2.		
	
4.	Methods	validation	
	
Methods	 validation	 was	 performed	 according	 to	 the	
international	 conference	 on	 harmonization	 (ICH)	 guidelines	
[20]	for	the	proposed	methods.	
	
	
4.1.	Linearity	
	
Under	 optimum	 experimental	 conditions,	 ACM	 was	
determined	 in	 triplicates	 in	 the	 range	 of	 2‐22	 µg/mL	 for	 1DD	
and	 MCR	 methods	 and	 in	 the	 range	 of	 0.4‐1.4	 μg/band	 for	
HPTLC	method,	Table	3.	
	
4.2.	Range		
	
The	 specified	 range	 is	 derived	 from	 linearity	 studies	 and	
depends	 on	 the	 application	 of	 analytical	 procedure.	 The	
concentration	 of	 ACM	 present	 in	 pharmaceutical	 preparation	
gave	accurate	and	precise	results	with	the	suggested	methods	
as	shown	in	Table	3.	
	
4.3.	Accuracy	
	
Accuracy	 was	 assessed	 by	 the	 standard	 addition	
technique	 and	 through	 analysis	 of	 market	 pharmaceutical	
preparation	by	the	proposed	methods.	The	resulting	synthetic	
mixtures	(of	pure	drug	portions	added	to	dosage	form)	were	
assayed	 and	 the	 found	 concentration	 of	 pure	 drug	 portions	
were	 compared	 to	 those	 expected.	 The	 good	 recoveries	 of	
pure	 drug	 samples	 suggest	 good	 accuracy	 of	 the	 proposed	
methods,	Table	2.	
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Table	4.	Parameters	of	system	suitability	of	the	developed	HPTLC	method	for	the	determination	of	ACM	in	presence	of	DEG.	
Parameters	 ACM	 DEG 
Capacity	factor	(K')		 2 6	
Symmetry	factor	 1.03 0.83 
Resolution	(Rs) 6.62
Selectivity	(α)		 2.43
	
	
Table	5.	 Statistical	analysis	of	 the	 three	proposed	methods	 (1DD	spectrophotometric	method,	Mean	centering	method	and	HPTLC	method)	and	 the	 reported	
HPLC	method	for	determination	of	ACM	in	Ostmap®	capsules.	
Parameters	 1DD	spectrophotometric	method Mean	centering	method HPTLC	method Reported	HPLC	method	a
Mean	 101.23	 101.28	 99.88	 102.86	
SD	 1.008	 1.758 1.004 1.682	
Variance	 1.0151	 3.091	 1.008	 2.830	
n	 6	 6	 6	 6	
Student’s	t‐test	b	(2.228)	 0.075	 0.142	 0.006 -	
F‐	test	b	(5.050)	 2.788	 1.092 2.807 - 
a	HPLC	determination	of	ACM	using	acetonitrile:water	(80:20,	v:v)	as	mobile	phase	and	UV	detection	at	280	nm	[4].	
b	The	values	between	parenthesis	are	corresponding	to	the	theoretical	values	of	t	and	F	(p	=	0.05).	
	
	
4.4.	Precision	
	
4.4.1.	Repeatability	
	
Two	concentrations	of	ACM	(6,	20	µg/mL)	for	1DD	method,	
(4,	 12	 µg/mL)	 for	 MCR	 method	 and	 (0.6,	 1.2	 µg/band)	 for	
HPTLC	method	were	determined	in	triplicates	in	the	same	day	
to	 estimate	 intraday	 variation.	 Good	 results	 and	 acceptable	
relative	standard	deviation	(RSD%)	are	shown	in	Table	3.		
	
4.4.2.	Intermediate	precision	
	
The	 previous	 procedures	 were	 repeated	 on	 the	 same	
concentrations	seven	times	on	different	four	days	to	determine	
the	 intermediate	 precision.	 Good	 results	 and	 acceptable	
relative	standard	deviation	(RSD%)	shown	in	Table	3.	
	
4.5.	Specificity		
	
It	 was	 evaluated	 by	 analysis	 of	 different	 synthetic	
laboratory	 prepared	 mixtures	 containing	 different	 ratios	 of	
ACM	 spiked	 with	 appropriate	 levels	 of	 DEG.	 Demonstrating	
that	 the	assay	 results	are	unaffected	by	 the	presence	of	DEG	
prove	specificity	of	the	methods	as	shown	in	Table	1.	
	
4.6.	Detection	and	quantitation	limits	
	
For	 spectrophotometric	 methods	 (1DD	 and	 MCR),	 the	
approach	based	on	the	standard	deviation	of	the	response	and	
the	 slope	 was	 used	 for	 determining	 the	 detection	 and	
quantitation	limits,	Table	3.	
	
LOD	=	3.3	x	SD/slope	[20]	 	 	 	 (4)
	 		
	
LOQ	=	10	x	SD/slope	[20]	 	 	 	 (5)	
	
For	 HPTLC	 method,	 as	 it	 exhibits	 baseline	 noise,	 the	
detection	 limit	 is	 determined	 by	 signal‐to‐noise	 ratio.	
Determination	 of	 signal‐	 to‐noise	 ratio	 is	made	 by	 comparing	
the	 measured	 signals	 of	 samples	 with	 known	 low	
concentrations	 of	 analyte	 with	 those	 of	 blank	 samples.	 For	
detection	limit,	determine	the	minimum	concentration	at	which	
the	 analyte	 can	be	detected.	 For	quantitation	 limit,	 determine	
the	 minimum	 concentration	 at	 which	 the	 analyte	 can	 be	
quantified	 [20].	 Acceptable	 detection	 and	 quantitation	 limits	
are	shown	in	Table	3.		
	
4.7.	Robustness	
	
The	 robustness	of	an	analytical	procedure	 is	a	measure	of	
its	capacity	to	remain	unaffected	by	small	deliberate	variations	
in	 method	 parameters	 and	 provides	 an	 indication	 of	 its	
reliability	during	normal	usage.		
For	HPTLC	method,	the	organic	strength	of	the	developing	
system	 was	 deliberately	 changed	 by	 ±0.5	 mL	 and	 it	 has	 no	
significant	 effect	 on	 Rf	 values	 or	 symmetry	 of	 the	 peaks	 as	
shown	 in	 Table	 3.	 However,	 small	 changes	 in	 the	 volume	 of	
glacial	acetic	acid	greatly	affect	separation	of	DEG.	
	
4.8.	System	suitability	
	
ICH	states	that	system	suitability	tests	are	an	integral	part	
of	many	analytical	methods,	especially	liquid	chromatographic	
methods.	 They	 are	 used	 to	 verify	 that	 the	 resolution	 and	
reproducibility	of	the	chromatographic	system	are	adequate	for	
the	 analysis	 to	 be	 done.	 Parameters	 including	 resolution	 (Rs),	
capacity	 factor	 (k'),	 peak	 symmetry	 and	 selectivity	 factor	 (α)	
were	calculated	as	shown	in	Table	4.		
The	 results	 obtained	 by	 the	 proposed	 methods	 were	
statistically	 compared	 with	 those	 obtained	 by	 the	 reported	
HPLC	method	using	t‐	and	F‐	tests.	The	values	obtained	are	less	
than	the	theoretical	ones	indicating	that	there	is	no	significant	
difference	 between	 the	 proposed	 methods	 and	 the	 reported	
HPLC	method	with	respect	to	accuracy	and	precision,	Table	5.	
	
5.	Conclusion	
	
The	 present	 work	 introduces	 simple,	 sensitive	 and	 rapid	
methods	 that	 are	 performed	 to	 determine	 ACM	 in	 pure	 form	
and	 in	 pharmaceutical	 preparation.	 The	 spectrophotometric	
methods	 are	 simple,	 less	 time	 consuming	 and	 economic	
stability	indicating	method	compared	to	published	LC	methods.	
Compared	 to	 the	 derivative	 method,	 MCR	 eliminates	 the	
derivative	 step	 and	 so	 the	 signal‐to‐noise	 ratio	 is	 enhanced.	
Moreover,	 it	 was	 more	 selective	 than	 the	 1DD	 spectrophoto‐
metric	method.	
The	HPTLC	method	has	the	advantage	that	several	samples	
can	be	run	simultaneously	using	a	small	quantity	of	developing	
system.	 It	 can	 provide	 high	 sensitivity	 and	 selectivity,	 in	
addition	to	separation	of	ACM	from	DEG.	
The	 proposed	 methods	 showed	 high	 sensitivity,	 accuracy,	
reproducibility	and	selectivity.	Moreover,	these	methods	can	be	
used	as	stability	 indicating	methods.	These	merits	suggest	 the	
use	 of	 the	 proposed	 methods	 in	 routine	 and	 quality	 control	
analysis	 without	 interference	 of	 commonly	 encountered	
pharmaceutical	preparation	additives.	
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